International prospective registry on local treatment approaches in myxoid liposarcomas
Last updated: February 12, 2020
To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)
Dutch title
Internationale prospectieve registratie voor lokale behandelingen in myxoid liposarcomen
Acronym
Doremy Registry
Reference code
NCT04699292
Intervention model
Observational cohort study
Full description
In order to confirm the promising results of the 36 Gy dose level in the DOREMY trial (NCT02106312) and to compare outcome with other local treatment approaches
Inclusion criteria
- Age > 18 years
- By biopsy proven myxoid liposarcoma
- Performance score ECOG 0-2
- Written informed consent to share coded information in this international Registry
Exclusion criteria
- Prior radiotherapy to target area
- Pregnancy
Locations Netherlands
- The Netherlands Cancer Institute
- Academisch Medisch Centrum
- Universitair Medisch Centrum Groningen
- Leids Universitair Medisch Centrum
- Maastro Clinic
- Radboudumc
Contact
Name: dr. R.L.M. Haas
E-mail: r.haas@nki.nl
Phone: +31 (0)205129111
Address: NKI-AVL, Plesmanlaan 121, 1066 CX Amsterdam
Downloads:
Download Link | Size | Format |
---|---|---|
C1 Doremy Protocol | 221 Kb |